<SEC-DOCUMENT>0002007191-25-000075-index.html : 20251217
<SEC-HEADER>0002007191-25-000075.hdr.sgml : 20251217
<ACCEPTANCE-DATETIME>20251217160657
ACCESSION NUMBER:		0002007191-25-000075
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20251217
FILED AS OF DATE:		20251217
DATE AS OF CHANGE:		20251217

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Telix Pharmaceuticals Ltd
		CENTRAL INDEX KEY:			0002007191
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			C3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-42128
		FILM NUMBER:		251579307

	BUSINESS ADDRESS:	
		STREET 1:		55 FLEMINGTON ROAD
		CITY:			NORTH MELBOURNE
		STATE:			C3
		ZIP:			3051
		BUSINESS PHONE:		61 3 9093 3855

	MAIL ADDRESS:	
		STREET 1:		55 FLEMINGTON ROAD
		CITY:			NORTH MELBOURNE
		STATE:			C3
		ZIP:			3051
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>k6prostupdate.htm
<DESCRIPTION>CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS
<TEXT>
Document 1 - file: k6prostupdate.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>prostactpr17.htm
<DESCRIPTION>EX-99.1
<TEXT>
Document 2 - file: prostactpr17.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image1.gif
<DESCRIPTION>GRAPHIC
<TEXT>
Document 3 - file: image1.gif

</DOCUMENT>
</SEC-DOCUMENT>